A macrine cells are retinal interneurons essential for visual function, as they modulate retinal signaling on retinal ganglion cells (RGCs). 1 More than 30 types of amacrine cells in the mammalian retina can be classified by morphology, physiology, stratification patterns, or expression of specific markers. [2] [3] [4] [5] In the developing retina, amacrine cells are born at the same time as RGCs, and many of them even migrate to the same layer of the retina. 6, 7 Interestingly, amacrine cells appear to resist neurodegeneration after either photoreceptor or RGC death. 8 The signaling of RGC survival has been well-studied 9 -12 ; however, little is known about amacrine cell biology. For example, what is the molecular basis for their resistance to degeneration upon loss of their targets (RGCs)? Why do they not differentiate their neurites into axons and dendrites as RGCs do? In this study, we characterized amacrine cell biology in vivo and in vitro, using highly purified cultures of amacrine cells. These data present a comprehensive comparative analysis of two neighboring central nervous system (CNS) neurons, and demonstrate fundamental differences between RGCs and amacrine cells in gene expression and survival signaling.
METHODS Animals
Sprague-Dawley rats were used for these experiments in compliance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and in accordance with institutional animal care and use committee review and approval.
Amacrine Cell and RGC Purification
Amacrine cells and RGCs were purified by immunopanning as previously described. 9, 11 Briefly, embryonic and postnatal rat retinas were dissociated with papain (Worthington, Lakewood, NJ) and mechanically triturated to obtain a single-cell suspension. Enrichment of amacrine cells to 88% purity was achieved after depleting rat macrophages (1:75, AI A51240; Accurate Chemical, Westbury, NY) and T11d7-and Ox7-positive cells (including RGCs) and immunopanning for Vc1.1-positive cells 13 (see Fig. 1 and Supplementary Table S1; all Supplementary Tables are available at http://www.iovs.org/cgi/content/full/51/7/ 3800/DC1).
RNA Preparation, Microarray Hybridization, and Data Analysis
Amacrine cells from embryonic (E20) and early postnatal (P5, P11) rats were acutely purified. 11 Total RNA was extracted (RNeasy; Qiagen, Valencia, CA) and shipped to the NIH Neuroscience Microarray Consortium (at the University of California Los Angeles), where it was amplified and processed for hybridization onto rat genome arrays (RAE 230 2.0 GeneChip; Affymetrix, Santa Clara, CA). Three microarrays were used for each postnatal amacrine cell age (P5, P11), and four were used for E20 amacrine cells. RNA collected from independent samples obtained on different days served as the starting material for each microarray.
Raw data files were analyzed (Microarray Suite 5.0; Affymetrix), and statistical analysis was performed (Excel; Microsoft, Redmond, WA; and NetAffx Analysis Center; Affymetrix) as described in the Results section. Amacrine cell microarray data have been deposited in the NIH Neuroscience Microarray Consortium database (http://np2. ctrl.ucla.edu/np2/home.do) and are also available in Supplementary  Table S1 .
Comparison of Amacrine Cell and RGC Gene Expression Profiles
We compared the gene expression profile of amacrine cells to previously published data on RGCs.
14 Since the microarray platforms used for amacrine cells and RGCs were different (RAE 230 2.0 and RG34U A-C, respectively; Affymetrix), we developed a method for probe set matching. Using the "Array Comparison Spreadsheets" from Affymetrix (http://www.affymetrix.com/support/technical/manual/comparison_spreadsheets_manual.pdf), we found that of 31,099 probe sets in the RAE 230 2.0 array and 26,379 probe sets in the RG34U A-C array set, 16 ,749 rat genes were probed by both platforms, allowing us to analyze cross-platform data representing 54% of the amacrine cell probes and 63% of the RGC probes.
One of the caveats in the use of the Good Match Spreadsheets is that the relation of probe sets between RAE 230 2.0 and RG 34UA-C arrays is not one to one, but rather many to one. 15 We eliminated duplicates in our datasets by removing the probes with the lowest percentage "present" call (Affymetrix algorithm) across samples and then the lowest expression levels across all ages. According to these criteria, we also removed probes with the same UniGene identification numbers, 16 which yielded a final pool of 14,457 shared unique probes between the amacrine and RGC datasets (http://www.ncbi.nlm.nih-.gov/UniGene; provided in the public domain by the National Center for Biotechnology Information, Bethesda, MD). The final probe comparison spreadsheet is available in Supplementary Table S2 .
To compare gene expression levels for the full probe set between amacrine cells and RGCs (as in Fig. 5 ), analysis of the gene expression profiles was performed independent of expression levels, to avoid the hazards of cross-platform normalization. We generated a ranking system, where the average of three to four biological replicates for each probe within one dataset was ranked according to its expression level compared with the rest of the probes within that dataset. The highest expressed probe in amacrine cells received a rank of 1 and so forth; the same methods was used for the RGCs. Rankings within an ontology were averaged for each cell type at each age studied, creating the index used in Figure 5 .
When directly comparing expression levels of a subset of genes (as in Fig. 6 ), we normalized the datasets by comparing the average of 14,457 probes for amacrine cells and RGCs at each developmental age. The adjusted RGC absolute expression levels were calculated by multiplying the RGC expression levels by a ratio factor generated by dividing the normalized, average expression level of all amacrine cell probes by the normalized, average expression level of all RGC probes.
Quantitative Real-Time Reverse Transcription-PCR
To validate the microarray data, we performed quantitative real-time PCR (qRT-PCR) and compared the expression levels of a subset of genes of interest between E20 and P11 amacrine cells. Total RNA was extracted from acutely purified cells as described above, of which 1 g was reversed transcribed into cDNA (iScript; Bio-Rad, Hercules, CA). Equal amounts of cDNA were further amplified by real time-PCR (iQ SYBR Green Supermix; Bio-Rad). We used 18S ribosomal RNA as an internal reference gene. Primers used were as follows: Calb1 (forward): TGCAGGCACGAAAGAAGGCTGG; Calb1 (reverse): CGGTGGG-TAAGACATGGGCCAAC; Dapk1 (forward): CTGATGGGCGCCAACGT-GGA; Dapk1 (reverse): CCGCAGTCTTGCCAGGAGCC; Rasgrf1 (forward): GCGCTGCGTGACAGAGTGGA; Rasgrf1 (reverse): TGGC-CCCCAGGGCTTCTCAG; C1q-L1 (forward): CGGCCAGCGGCAAGTT-TACA; C1q-L1 (reverse): GCAATGGCACTGGCCCGCAC; and 18s (forward): GAACTGAGGCCATGATTAAGAG; 18s (reverse): CATTC-TTGGCAAATGCTTTC. The change ratio was calculated by using the ⌬⌬ Ct method. 17 Reactions were run with five replicates per primer pair and repeated at least three times on different days.
Immunofluorescence
For quantification of the purity of amacrine cell cultures, amacrine cells were acutely purified, plated on PDL-coated glass coverslips, and immunostained at 1 day in vitro (DIV). Briefly, the cells were fixed with 4% PFA for 5 minutes, rinsed three times in PBS, and permeabilized for 5 minutes with 1% Triton X-100. After another round of rinses in PBS, the cells were blocked and permeabilized with 20% donkey serum and 0.1% Triton X-100 in antibody buffer (150 mM NaCl, 50 mM Tris base, 1% BSA, 100 mM L-lysine, 0.04% Na azide [pH 7.4]). Sheep anti-Chx10 (1:200, AB9016; Millipore, Billerica, MA) and mouse anti-syntaxin (1: 200, ab3265; Abcam, Cambridge, MA) antibodies were incubated overnight at 4°C. Secondary antibodies (donkey anti-mouse Alexa 488 and donkey anti-sheep Alexa 594; Invitrogen, Carlsbad, CA) were used at a dilution 1:500 and incubated for 4 hours in the dark at room temperature. Coverslips were later mounted on glass slides (Vectashield with DAPI; Vector Laboratories, Burlingame, CA) and examined with an inverted fluorescence microscope (Carl Zeiss Meditec, Dublin, CA).
For immunostaining of polarity genes, RGCs and amacrine cells acutely purified from the same animals were cultured on PDL-coated glass coverslips with or without laminin (Trevigen, Gaithersburg, MD), respectively, in serum-free medium. At 3 DIV, cells were incubated at 37°C with PFA (2% final concentration) for 30 minutes, postfixed with 4% PFA for 10 minutes at room temperature and the coverslips were rinsed three times with PBS and blocked for 30 minutes with 20% normal goat serum and 0.2% Triton X-100 in antibody buffer. Primary antibodies were incubated overnight at 4°C as follows: rabbit anti-Par6 (1:100, sc-25,525, Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-atypical PKC (1:100, sc-216, Santa Cruz Biotechnology), mouse anti-Limk1 (1:500, L13020; BD Biosciences, Mississauga, ON Canada), and mouse anti-Stat3 (1:100, 9139, Cell Signaling Technology). Secondary detection was performed with fluorescent antibodies at a 1:500 (Alexa-488; Invitrogen). TRITC-conjugated phalloidin (3.3 g/mL; P1951; Sigma-Aldrich, St. Louis, MO) was added together with the secondary antibodies and incubated overnight at 4°C. The coverslips were mounted on glass slides and examined with an inverted fluorescence microscope (Carl Zeiss Meditec, Inc.). Cells immunostained with the same antibody were exposed to the same fluorescence intensity. Exposure was carefully controlled to maximize comparison between amacrine and RGC immunofluorescence and to better capture the expression of polarity genes in the neurites.
Amacrine Cell Culture and Survival Assays
Acutely purified amacrine cells were plated at different densities (8, 47, or 156 cells/mm 2 ) in tissue-culture wells coated with PDL (70 kDa, 10 g/mL; Sigma-Aldrich) in serum-free medium (Neurobasal; InvitrogenGibco) as described 9, 12 containing insulin (50 ng/mL), forskolin (5 mM; Sigma-Aldrich), CNTF (10 ng/mL), BDNF (50 ng/mL; Peprotech, Rocky Hill, NJ), and a modified version of B27 18 with antibiotics (1X PenStrep; Invitrogen-Gibco). The cultures were maintained at 37°C in a humidified incubator with 10% CO 2 . To evaluate cell survival as a function of cell density (see Fig. 7A ), we used calcein-AM (1 M; Invitrogen, Carlsbad, CA) and the nuclear dye DAPI. Initially, we intended to use DAPI as a nuclear maker for all cells and calcein as a marker of living cells. This method would allow unequivocal counting of cell viability. To our surprise, when imaging the cells under a fluorescence microscope, we saw exclusion of DAPI by calcein-positive cells. We then added a third dye (propidium iodide) and confirmed this result. Invitrogen states that DAPI is cell impermeant when added at low doses. We used DAPI at a final concentration of 30 ng/mL. Cells that were calcein ϩ /DAPI Ϫ were considered to be alive; dead cells were DAPI ϩ . For the rest of the survival experiments (Fig. 7B, 7C ), the cells were plated at the lowest density (8 cells/mm 2 ). We used calcein-AM (1 M) and the nuclear dyes Hoechst (1:5000; Invitrogen) and propidium iodide (PI; 1:5000; Sigma-Aldrich) were added to the media for 30 to 45 minutes. Live cells were defined as calcein ϩ /PI -; all PI ϩ cells were classified as dead. The cells were manually counted, and at least three wells per condition were averaged within each experiment. The experiments were repeated at least five times to confirm the results.
Immunoblot and Densitometric Analysis
Acutely purified amacrine cells were resuspended in serum-free medium, with or without various peptide trophic factors and pharmacologic inhibitors, and rotated for 2 hours at 37°C, after which the cells were processed for protein extraction according to standard protocols. 
RESULTS

Amacrine Cell Purification
Amacrine cells from E20 and P8 rats were acutely purified by immunopanning with the Vc1.1 antibody 19 and cultured in serum-free medium (Fig. 1A) . Since amacrine cells only make up to 9% to 12% of the cells in the retina 12 and ϳ40% of the cells in the inner nuclear layer of the mouse retina, 3, 20 we performed sequential immunopanning to obtain a high amacrine cell yield (Fig. 1A) . 12 To confirm the purity of the cultured cells, we performed double immunostaining using both the monoclonal antibody HPC-1 (Fig. 1B) , which recognizes syntaxin, an amacrine cell marker 21, 22 and an antibody against the pan-bipolar cell marker Chx10. 23 We found that 88% of the purified cells were immunopositive for HPC-1 and 7% were immunopositive for Chx10, whereas no cells were immunoreactive for both antibodies (Fig. 2) . Thus, the immunopanning technique yielded a culture highly enriched in amacrine cells, although data from postnatal amacrine cell cultures did reflect slight contamination from bipolar cells.
Amacrine Cell Gene Expression Profile
What genes do amacrine cells express during development? Recent analyses of amacrine cell gene expression at the single cell level have yielded beautiful pictures of the molecular diversity of these cells, 24 ,25 but we had undertaken an overview of amacrine cell gene profiling at a population level through perinatal development. Amacrine cell mRNAs isolated from acutely purified E20, P5, and P11 rats were hybridized to expression arrays (Rat Genome 230 2.0; Affymetrix) containing 31,099 probes representing more than 28,000 rat genes. Three to four biological replicates were collected for each age, and we found little intersample variability within the same age group (Pearson r 2 Ն 0.90 for all pairwise comparisons; Fig.  3A) .
The amacrine cells expressed 21,899 (70%) of the 31,099 probes in at least two or more of the samples at one or more ages (Fig. 3B) , and 16,247 probes (52%) were expressed at all ages, according to Affymetrix's "present" call algorithm. Of those 21,899 probes present in at least two or more of the samples at one or more ages, 2468 probes (11%) changed at least threefold during development, 344 (2%) changed at least 10-fold, and 120 (0.5%) changed at least 20-fold (Fig. 3C , Table   1 ). When ANOVA was used to calculate probes that changed more than threefold with a P Ͻ 0.05, 2231 probes (ϳ10%) changed between E20 and P11 (without correction), and 374 probes (1.7%) changed if a Bonferroni correction was used (Fig. 3B ). These represent two extremes of statistical validation; the true number of changing probes probably lies between these two numbers. To validate these results, we performed quantitative reverse transcription real-time PCR (qRT-PCR) on several genes that changed more than 10-fold by microarray (Calb1, Rasgrf1, and C1ql1) and a survival-associated gene, Dapk1. We confirmed the consistency between microarray and qRT-PCR data (Fig. 4) , Consistent with our previous work, 14 there were differences in the change ratio between microarray and RT-PCR data; however, the direction of the change was the same. These data, together with the immunostaining for polarity genes presented below (see Fig.  6 ), help validate the microarray data.
To further classify the gene expression profile of amacrine cells, we distributed the 31,099 probes of the RAE 230 2.0 arrays into overlapping gene ontology categories by using data available from Affymetrix's Netaffx Analysis Center (http:// www.affymetrix.com/analysis/index.affx) and the Gene Ontology Consortium database (http://amigo.geneontology.org/cgibin/amigo/go.cgi). 26 We fit 16,753 (54%) probes into 27 partially overlapping categories, and we found that amacrine cells express 52% to 89% of the probes in each category. Categories such as mitochondria, cell cycle, chromosome, and ubiquitin were overrepresented and the category G-protein was underrepresented ( 2 ; Fig. 3D ). We next analyzed the fraction of probes within each category that changed at least threefold during development. We found that 11 of the 27 categories were significantly regulated during development ( 2 ; Fig. 3E ), including neurotransmission/tter, plasma membrane, and migration. These results may reflect the vast differentiation that amacrine cells undergo between E20 and P11, [27] [28] [29] [30] [31] when they start secreting neurotransmitters and there are changes in the levels of their receptors on the plasma membrane. At this same developmental stage, amacrine cells migrate to populate the INL and GCL. 32 Conversely, probes in categories such as cell cycle, polarity, and apoptosis were less likely to change during development, as the peak of amacrine cell generation occurs embryonically. 6, 20, 28, 33, 34 It is possible that some of the probes in these categories also change at the protein level during development by posttranslational regulation. Compartmentalization, binding with inactivating partners or changes in the phosphorylation levels are not reflected in these microarray analyses (Fig. 3E , Table 2 ). These data suggest that the amacrine cell transcriptome is very dynamic during development, similar to our prior findings with purified RGCs.
14 Changes in amacrine cell gene expression could be due in part to a change in the subpopulations of amacrine cells purified by immunopanning at embryonic and postnatal ages, although we have yields of well over 50%, suggesting that we are purifying a broad swath of amacrine cell subtypes at all these ages. To further validate our dataset, we compared our E20 amacrine cell data against recently published P0 amacrine cell and RGC single-cell expression profiling. 24, 25 Consistent with their results, we found that amacrine cells (and not RGCs) expressed high levels of the transcription factor AP-2␤ (TCFAP-2␤) and that all the samples of amacrine cells expressed high levels of neuronal leucine-rich repeat protein-3 (Lrrn3), two recently validated amacrine cell markers. 24 We also observed amacrine cell expression of probe sets for gamma synuclein (Sncg), early B-cell factor 3 (Ebf3), and neurofilament 68 (Nefl), genes previously described to be highly enriched in RGCs. [35] [36] [37] These discrepancies may be explained by several experimental differences, including posttranscriptional control of expression (not explored here), neuronal age and species (E20 rat versus P0 mouse), starting RNA material (millions of purified amacrine cells including different subtypes pooled together versus single cells analyzed separately), potential amplification artifacts (less amplification is necessary for pooled cells), and potential for contamination or cellular misidentification in either dataset.
Comparison of Amacrine Cell and RGC Gene Expression through Development
We next compared our gene expression datasets of amacrine cells and RGCs. 14 We identified 14,457 probes shared between the different microarray platforms of the two datasets-more than half of the total data. The manipulation necessary for this comparison across different platforms (see the Methods section) may have decreased the robustness of these analyses, but the large number of shared, cross-platform probes would be expected to compensate for this limitation. Of the 14,457 probes shared between the two array types (see the Methods section; Fig. 5A ), 8575 (59%) were "present" by Affymetrix algorithm in at least two samples of one age in both gene chip datasets; 2640 (18%) were present only in amacrine cells, and 432 (3%) were expressed only in RGCs. The remaining 2910 (20%) were absent from both cell types. A breakdown of these numbers at E20, P5, and P11 is shown in Figure 5A . Of the 3072 probes expressed at any age either by amacrine cells or by RGCs but not by both cell types, amacrine cells expressed more unique genes than RGCs at all ages ( Fig. 5A ) and across all 35 gene ontologies analyzed. We found 25 neurotransmitterassociated genes that were exclusively expressed by amacrine cells at all ages but not by RGCs (Table 2 ) and only two specific to RGCs. Occasionally, probes had higher absolute expression levels in RGCs than in amacrine cells, but the Affymetrix algorithm called them "absent," as commonly occurs when in analysis of probes with low absolute levels of expression. The higher number of neurotransmitter-associated probes expressed exclusively by amacrine cells and not RGCs is consistent with the transmitter variety described in amacrine cells as a whole.
2,38 -40
We next compared the gene expression levels for the probes expressed by both RGCs and amacrine cells at different ages (Fig. 5A) . Since the absolute gene expression levels for amacrine cells and for RGCs are on different, arbitrary scales, we converted absolute gene expression levels to ranked gene expression levels for each cell type, assigning the gene with the highest amacrine cell expression at a given age a rank of 1, and continuing down to a rank of 10,525 for E20, 10,574 for P5, and 10,502 for P11 (the number of genes present at each of those ages) and repeated the process for the RGC genes. Since RGCs expressed fewer genes at every age than did the amacrine cells, the RGC rank list was scaled to 10,525 for E20, and so on, to match the length of the amacrine cell gene list. The genes "present" only in amacrine cells were given terminal rankings (e.g., 10,526) in RGCs, and vice versa, at each age. We then compared the ranked expression for each gene between the amacrine cells and the RGCs, to create a simple index. The average of the differences between rankings of amacrine cells and RGCs compared at E20, P5, and P11 of all the probes within a given gene ontology is shown in Figure 5B , where the scale shows genes ontologies with genes that are more highly expressed in RGCs at one end and more highly expressed in amacrine cells at the other end. For example, RGCs at all ages expressed higher levels of genes within the neurotransmi-and immune ontologies ( Fig. 5B, top ; Table 2 ). This difference could be because amacrine cells secrete a variety of neurotransmitters and RGCs only a few but at higher levels, thus demonstrating greater differences in gene expression rankings.
On the bottom of Figure 5B , amacrine cells expressed higher levels of genes in the categories chromatin, DNA, and transcription. The index identified differences between amacrine cells and RGCs that were largely consistent across E20, P5, and P11 ages in most ontologies, except for a few ontologies such as polarity, neurit-, chromosome, and neurotransmi-which demonstrated greater developmental variability across this age range between these two neuron types. Comparing the expression profile of more than 50 polarityassociated genes, we found that some are differentially regulated during amacrine cell development or differ between amacrine cells and RGCs (Table 3, Figs. 6B, 6D, 6F, 6H ). For example, microtubule affinity-regulating kinase 2 (Mark2), which negatively regulates dendrite development in cultured hippocampal neurons, 41 was expressed at moderate levels by amacrine cells but was not detected in RGCs. Conversely, signal transducer and activator of transcription 3 (Stat3), which when activated can promote neurite outgrowth in primary sensory neurons, 42 was expressed fivefold more in RGCs than in amacrine cells (Fig. 6B) . Consistent with previous findings, 43 RGCs were immunopositive for Stat3, but we found that amacrine cell immunostaining for Stat3 was barely detectable above background (Fig. 6A) , consistent with the microarray data (Fig. 6B) .
We next investigated the expression and localization of a few other polarity proteins between the two cell types during neurite growth in vitro. All immunostaining performed trended in the same direction as the microarray data, adding confidence to the data's reliability. We did not detect any differences in the expression or localization of some proteins, including Par6 (Fig. 6C) . Others, however, were differentially expressed or localized. For example, atypical protein kinase C (aPKC), which is a part of the Par3/Par6/aPKC complex necessary to establish cell polarity in mammalian epithelial cells, 44 and whose activity is necessary for neurite polarization and axon formation in hippocampal neurons, 45 was localized in the cytoplasm and along initial neurite segments in RGCs, but it was only present in the cytoplasm of amacrine cells (Fig. 6E) . Limk1, a kinase that regulates actin cytoskeleton dynamics 46, 47 and controls growth cone motility, 48 was highly localized to the growth cones in RGCs and also present in the lamellipodia of amacrine cells (Fig. 6G) . Of interest, although in RGCs Limk1 has a ubiquitous distribution in the cell body; it is clearly excluded from the nucleus in amacrine cells, which may suggest a difference in its biological functioning between these two cell types. 49 Although the functional role of these expressed polarity genes in amacrine cells remains to be tested, taken together, these data suggest that amacrine cells express many of the genes important in neurite differentiation (that is, axon versus dendrite differentiation), and that differential protein localization may explain the differences in axon/dendrite polarization in these cell types.
Amacrine Cell Survival Signaling Pathways
It is a general tenet in neuroscience that neurons are dependent on their targets for survival, both during development and in the adult. 10 In vivo in optic neuropathies, however, amacrine cells appear to resist degeneration after RGC death. 8 Although the molecular signals sufficient to promote RGC After eliminating duplicate probes for the same gene, 14,457 probes were represented in both datasets. Of these, most were "present" in both RGCs and amacrine cells at all three ages, but over 2600 were expressed uniquely by amacrine cells, and over 300 were expressed uniquely by RGCs, comparing at each age. The area of the circles is not exactly proportional to the number of probes they contain. (B) Average difference in ranked expression between amacrine cells and RGCs in 35 overlapping gene ontologies. Only probes that were "present" in both datasets were included in the analysis. (See the Methods and Results section for average ranking details; the datasets and the ranking for each probe can be found in Supplementary Table S2.) survival have been extensively studied and characterized, 9,11,50 -55 little is known about the cues that regulate amacrine cell survival. We analyzed survival-related genes with gene ontologies containing apoptosis, MAPK, PI3K, and a few hand-picked additional genes. We identified the subset of these genes that differed between amacrine cells and RGCs. Of 112 probes found in both datasets, 84 (75%) were "present" in both the amacrine cells and RGCs, 19 (17%) probes were "present" only in amacrine cells and 7 (7%) probes were unique to RGCs (Supplementary Table S3 .) Several interesting candidate genes differed, including ciliary neurotrophic factor receptor (Cntfr) and huntingtin (Htt), which were detected in amacrine cells but not in RGCs. Htt may play a role in survival signaling by enhancing BDNF axonal transport, 56 and is one of the binding partners of optineurin, 57 a protein with mutations that have been associated with primary open-angle glaucoma. 58 Although optineurin expression in RGCs increases during development, 14, 59, 60 it would be interesting to explore whether the deficiency of its binding partner Htt may underlie the susceptibility of RGCs to neurodegeneration. Among the many genes expressed by both cell types were most of the bcl-2 family. However, RGCs expressed higher levels of the proapoptotic 14 Do the same signaling pathways mediate the survival of RGCs and amacrine cells? To address this question, we purified primary amacrine cells from P8 to P9 rats, cultured them in a variety of defined growth media without serum for up to 3 days, and quantified their survival by using a live/dead assay (see Methods). First, we found that amacrine cell survival was not enhanced by increasing cell density (Fig. 7A) , in contrast to RGC survival, 9 suggesting that amacrine cells may not secrete factors into the media that enhance their own survival in a paracrine fashion. Exogenous addition of brain-derived neurotrophic factor (BDNF) and ciliary neurotrophic factor (CNTF), two of the trophic peptides that most strongly support RGC survival, 9 ,61 had no effect on amacrine cell survival (Fig. 7B) . Indeed, at cell culture densities that are most likely too low for amacrine cells to condition the medium with paracrine signaling molecules, amacrine cell survival was remarkably high, even in the absence of peptide trophic factors. There was a modest effect of adding a modified B27 supplement containing hormones and antioxidants, 18 particularly in the absence of other peptide trophic factors (Fig. 7B ). This high, constitutive survival was observed solely from the constituents of the Sato supplement, 62 which includes putrescine, transferrin, progesterone, selenite, and albumin, plus pyruvate, glutamine, thyroid hormone, and n-acetyl cysteine (Fig. 7B) . These data suggest that amacrine cells depend more on hormone and antioxidant signals than on peptide trophic factors for their survival.
To explore which intracellular signaling pathways mediate the observed survival in vitro, we cultured amacrine cells in full Sato (FS) medium containing pharmacologic inhibitors for a subset of known survival signaling pathways. When amacrine cells were treated with the MEK1/2 specific inhibitor U0126, there was a threefold decrease in survival (Fig. 7C ). PI3K and JAK/STAT inhibitors (LY294002 and AG490, respectively) also decreased amacrine cell survival in vitro (Fig. 7C) . Although amacrine cells expressed TrkA, -B, and -C by microarray anal- ysis, addition of the Trk inhibitor K252a did not affect survival, consistent with the modest effect of exogenous BDNF on survival in these experiments (Figs. 7B, 7C ), suggesting that autocrine Trk signaling is not responsible for amacrine cell survival. We confirmed the specificity of the U0126, K252a, and LY294002 inhibitors by Western blot with amacrine cells acutely purified and allowed to recover for 2 hours at 37°C without peptide trophic factors in the presence of the inhibitors (Figs. 7D, 7E) . Again, addition of K252a did not affect ERK1/2 signaling compared with the control, consistent with its minimal effect on survival. The addition of either U0126 or LY294002 inhibited the activation of ERK1/2 and AKT, respectively, and impaired amacrine cell survival (Figs. 7D, 7E ). Taken together, these results show that amacrine cells require MAPK, PI3K, and JAK/STAT activation for survival, but we do not know what upstream signals are responsible for activating these pathways.
DISCUSSION Amacrine Cells' Transcriptome Changes during Early Retinal Development
We and others have previously reported on the transcriptomes of identified cell populations in the CNS, including RGCs, striatal and corticospinal motor neurons, 63, 64 and genetic labeling techniques have considerably expanded the scope of CNS neurons amenable to such isolation and analysis, either by cell-sorting fluorescent cells 65 or by directly purifying translated RNAs from neuronal subpopulations that express RNA binding proteins. 66 We highly purified amacrine cells by immunopanning and provide a database for the transcriptome of amacrine cells at three developmental ages (E20, P5 and P11). Previous datasets have been generated to study developmental changes in the gene expression of neighboring neurons, 63, 64 and this database, together with the RGC transcriptome, 14 yields a comprehensive description at a molecular level of two synaptically closely related CNS neurons. In addition, these data add significantly to the snapshot of single-cell gene expression profiling performed on 32 amacrine cells mostly from P0 and P5. 25 With at least 25 to 30 different morphologic subtypes of amacrine cells previously described, 67 ,68 a population-level profile of amacrine cell gene expression certainly adds value to the single cell data currently available. These data may provide opportunities in the future for better understanding retinal development, wiring, and degeneration, and ultimately CNS neurologic diseases.
Patterns of Gene Expression in Amacrine Cells and RGCs
Two cells that come from a common progenitor, migrate (in part) to the same retinal layer, and synaptically integrate in the same retinal layer, may be expected to share common gene expression. Indeed, we found that most genes (Ͼ74%) were expressed at similar levels in RGCs and amacrine cells at embryonic and postnatal ages. With an interest in pursuing the observed differences in the cell biology of amacrine cells and RGCs, however, we focused mainly on their differences in gene expression. We found that RGCs more highly expressed genes associated with the terms immune and neurotransmitter/mission and metabolic pathways, such as Nadh/Nadph. The role of molecules of the immune system in the CNS was first thought to be limited to inflammation, injury, and autoimmune disorders. Recent findings, in particular in the visual system, have shown that major histocompatibility complex (MHC) class I molecules and proteins of the complement cascade, such as C1q and C3, have an unexpected role in CNS development and plasticity. 69 -71 Our data provide a significant list of immune system genes expressed by both amacrine cells and RGCs, to help build hypotheses for the molecular pathway of synapse formation and elimination during development and after injury.
Similarly, the high expression levels of genes associated with ontologies such as DNA, chromatin, and transcription by amacrine cells compared with RGCs could underlie amacrine cell heterogeneity or plasticity during retinal development. With a more dynamic chromatin remodeling capacity, amacrine cells may express more varied sets of transcription factors or other downstream targets at different times, which could contribute to their cellular diversity.
Amacrine Cells' Resistance to Neurodegeneration
Both CNS and PNS neurons are strongly dependent on targetderived peptide trophic signals for their survival, and competition for target-derived signals is intimately related to neuronal survival and synapse formation during development. 72, 73 Most of the data for these observations have been derived from studies of long-projection neurons, and it is not known whether the same principles apply to locally integrated interneurons. In optic neuropathies such as glaucoma, when most of the RGCs die, amacrine cells are largely not affected, despite the loss of their major synaptic target. 8, 74 Furthermore, in rat optic nerve transection experiments in which Ͼ90% of the RGCs die within 2 to 4 weeks, amacrine cells continue to survive and express calbindin, calretinin, and GABAergic cell markers after 3 months. 8 Similarly, GABAergic amacrine cell subpopulations are resistant to retinal ischemia in a rat ischemia-reperfusion model. 75 Results of a study have suggested that amacrine cells require high concentrations of insulin for survival, 76 or that antagonizing TrkB receptor signaling in retinal explants decreases the number of nuclei in the inner nuclear layer 77 and, in vivo, reduces the number of parvalbumin-positive amacrine cells in the retina. 78 Interpretation of such experiments may be confounded by a decrease in the expression of phenotypic cell markers without cell death. 78, 79 We used our ability to highly purify and culture amacrine cells in defined, serum-free medium to ask whether the same trophic factors that strongly promote RGC survival 9 similarly promote amacrine cell survival in vitro. We found that peptide trophic factors did not significantly contribute to amacrine cell survival in vitro, even when amacrine cells were cultured at clonal density, despite expression of trkB, CNTF-Ra, LIF-R, and IGF-R1 detected on the microarrays. Blocking of MEK1/2 or PI3K signaling pathways significantly impaired survival, suggesting that these intracellular signaling pathways are necessary for amacrine cell survival and raising the question of how these pathways are being activated. The Western blot experiments in Figure 5 suggest that without the addition of exogenous peptide trophic factors, there is a basal activity of MEK1/2 and PI3K that is further increased when cells are grown in Sato supplement-containing medium.
Taken together, these data demonstrate that although RGC and amacrine cell survival are mediated through the same intracellular signaling pathways, 11 their requirement for exogenous peptide trophic factors differs. Survival of amacrine cells in our low-density cultures in the absence of exogenous peptide trophic factors suggests potential regulation by autocrine signaling 80 or by hormone or antioxidant support alone. Thus, these retinal interneurons may not depend on target RGCs for peptide trophic support.
Involvement of Amacrine Cell Properties in the CNS for Repair and Regeneration
To overcome the failure of adult mammalian CNS regeneration, neurons must survive and reextend their axons to their targets. It is intriguing to consider whether amacrine cells, which exhibit some survival independence from peptide trophic factors and which survive degenerative diseases affecting RGCs, may represent a residual retinal population of neurons that could be induced to replace the visual functions of lost RGCs. Understanding the molecular components that could allow amacrine cells to extend and differentiate axons may allow these cells to serve as a local source of RGC replacement in designing therapies targeted to cure blindness.
